Cite
MLA Citation
Patrick Wen et al.. “CTIM-13. PHASE 1 CLINICAL TRIAL OF ONCOLYTIC VIRAL IMMUNOTHERAPY WITH CAN-2409 + VALACYCLOVIR IN COMBINATION WITH NIVOLUMAB AND STANDARD OF CARE (SOC) IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG).” Neuro-oncology, vol. 23, 2021, p. vi52. http://access.bl.uk/ark:/81055/vdc_100146090179.0x00002b